Microcapsule for promoting proteolysis as well as preparation method and application thereof

By using microcapsules combined with aminopeptidase and papain in the digestive system, combining sodium alginate and calcium chloride carrier materials, the problem of instability of enzyme release in existing indigestion treatments is solved, and stable release in the small intestine is achieved and Recovery of digestive and absorption function.

CN118986921APending Publication Date: 2024-11-22NAT INST FOR NUTRITION & HEALTH CHINESE CENT FOR DISEASE CONTROL & PREVENTION +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411312969.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-20
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Among the existing treatment methods for indigestion, the stability of the compound digestive enzyme preparation is poor and the multi-layer coating preparation technology is complex, making it difficult to stably release enzymes in the small intestine, affecting the digestive and absorption function.

Method used

The combination of aminopeptidase and papain is used as the active ingredient, combined with sodium alginate and calcium chloride as the carrier material, and through a specific microcapsule structure design, the enzyme is stablely released in the small intestine without affecting the original function of the gastrointestinal tract.

Benefits of technology

It realizes stable release of enzyme in the small intestine, effectively promotes proteolysis, restores and maintains digestive and absorption functions, and enhances the body's immunity and resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005051239240000081
    Figure BDA0005051239240000081
  • Figure BDA0005051239240000091
    Figure BDA0005051239240000091
  • Figure BDA0005051239240000101
    Figure BDA0005051239240000101
Patent Text Reader

Abstract

The invention relates to a microcapsule for promoting proteolysis as well as a preparation method and application thereof. The microcapsule for promoting proteolysis comprises a carrier material and an active component embedded in the carrier material, the active component comprises a combination of aminopeptidase and papain; the carrier material comprises a combination of sodium alginate and calcium chloride. A specific complex enzyme combination is entrapped by a specific carrier material to obtain the microcapsule with a specific structure, the microcapsule can be stably released in small intestines after entering a digestive system, protein hydrolysis is effectively promoted, the original gastrointestinal protein digestion function is not influenced, and the microcapsule has the advantages of restoring and maintaining own digestion and absorption functions and improving the digestion efficiency. The active and important significance is realized on enhancing the self-immunity and the disease resistance of the body.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of microcapsules, and in particular to a microcapsule for promoting protein hydrolysis and a preparation method and application thereof. Background Art

[0002] Excessive intake of high-energy foods such as high-protein and high-fat foods will lead to metabolic disorders and enzyme secretion disorders. When the body's digestive metabolism is disordered and endocrine disorders occur, it is very easy to cause various diseases. When the body's protease secretion is insufficient, the ingested large-molecule protein cannot be promptly and effectively decomposed and absorbed, and accumulates in the body, which can cause mild indigestion and severe protein poisoning. Statistics show that due to changes in dietary structure, environmental changes, and the natural deterioration of the body's endocrine capacity with aging, the superposition of multiple factors has caused the risk of digestive system diseases to rise unprecedentedly, and the phenomenon of sub-health in the digestive system is common among the social population.

[0003] In the treatment of indigestion, medicine usually uses chemical drugs, yeast or Chinese herbal medicines. Long-term use of drugs not only causes irritation to the gastric and intestinal mucosa, but also has different degrees of toxic side effects. In addition, antibiotics will destroy the lactobacilli that maintain the function of the stomach and intestines while killing the bacteria, causing further damage to the digestive and absorption systems. Studies have found that an important factor causing indigestion in the human body is the lack of corresponding enzymes secreted by the human body, which causes the macromolecules ingested by the human body, such as proteins, starch polysaccharides, and fats, to be unable to be digested and absorbed by the human body within an effective time, and thus accumulate in the human digestive system, causing indigestion in the human body.

[0004] CN1943783A discloses a compound digestive enzyme preparation and a preparation method thereof, wherein the preparation is a micro-pill; the micro-pill is composed of an enteric digestive enzyme pellet core, an enteric coating layer wrapping the enteric digestive enzyme pellet core, a gastric digestive enzyme layer wrapping the enteric coating layer, and a gastric coating layer wrapping the gastric digestive enzyme layer. Although the compound digestive enzyme preparation of the invention contains enteric digestive enzymes and gastric digestive enzymes, the enzyme release rate is high and the therapeutic effect is good during use, but the preparation technology of the multi-layer coating is complicated and difficult to achieve, and the stability of the preparation is poor, and the activity of the enzyme will decrease after being placed for a period of time. Therefore, it is particularly important to develop a product that can be stably released in the small intestine after entering the digestive system, effectively promotes protein hydrolysis, and does not affect the original function of gastrointestinal protein digestion. Summary of the invention

[0005] In view of the deficiencies in the prior art, the purpose of the present invention is to provide a microcapsule for promoting protein hydrolysis and a preparation method and application thereof, and specifically to provide a microcapsule for promoting protein hydrolysis and a preparation method thereof and application thereof in the preparation of a product that improves protein digestion and hydrolysis.

[0006] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

[0007] In a first aspect, the present invention provides a microcapsule for promoting protein hydrolysis, wherein the microcapsule for promoting protein hydrolysis comprises a carrier material and an active ingredient embedded in the carrier material;

[0008] The active ingredients include a combination of aminopeptidase and papain;

[0009] The carrier material includes a combination of sodium alginate and calcium chloride.

[0010] The invention uses a specific carrier material to encapsulate a specific complex enzyme combination to obtain a microcapsule with a specific structure, wherein aminopeptidase and papain work synergistically to further enhance the digestion and hydrolysis effect of protein. The prepared microcapsule product can be stably released in the small intestine after entering the digestive system, effectively promoting protein hydrolysis without affecting the original function of gastrointestinal protein digestion, which has a positive significance for restoring and maintaining the self-digestion and absorption function, and enhancing the body's self-immunity and disease resistance.

[0011] Preferably, the mass ratio of the aminopeptidase to papain is (0.5-2):(2-5), for example, it can be 1:1, 1:1.5, 1:2, 1:2.5, 1:3, 1:3.5, 1:4, 1:5, 1:8, 1:8.5, 1:9, 1:9.5, 1:10, etc. Other specific point values ​​within this numerical range can be selected, which will not be repeated here.

[0012] Preferably, the mass ratio of sodium alginate to calcium chloride is (1-3):(0.5-2), for example, it can be 6:1, 5:1, 4:1, 3:1, 2:1, 1.5:1, 1:1, 1:1.5, 1:2, etc. Other specific point values ​​within this numerical range can be selected and will not be described here one by one.

[0013] Preferably, the microcapsules promoting protein hydrolysis further comprise a cationic polymer embedded in a carrier material.

[0014] Preferably, the cationic polymer comprises PLGA / DDAB nanomaterial.

[0015] Preferably, the mass ratio of the active ingredient to the cationic polymer is (50-100):1, for example, it can be 50:1, 55:1, 60:1, 65:1, 70:1, 75:1, 80:1, 85:1, 90:1, 95:1, 100:1, etc. Other specific point values ​​within this numerical range can be selected, and they will not be described one by one here.

[0016] In a second aspect, the present invention provides a method for preparing a microcapsule for promoting protein hydrolysis according to the first aspect, the preparation method comprising:

[0017] After the active ingredient and the carrier material solution are mixed, the microsphere droplets in the lower layer are collected by centrifugation to obtain the microcapsules that promote protein hydrolysis.

[0018] Preferably, the carrier material solution comprises a sodium alginate solution and a calcium chloride solution.

[0019] Preferably, the mixing is performed under stirring conditions.

[0020] Preferably, the stirring speed is 200-500rpm, for example, it can be 200rpm, 225rpm, 240rpm, 260rpm, 280rpm, 300rpm, 320rpm, 350rpm, 380rpm, 400rpm, 425rpm, 450rpm, 475rpm, 500rpm, etc. Other specific point values ​​within this numerical range can be selected, which will not be described here one by one.

[0021] Preferably, the mixing time is 30-60 min, for example, it can be 30 min, 32 min, 35 min, 38 min, 40 min, 42 min, 45 min, 48 min, 50 min, 52 min, 55 min, 58 min, 60 min, etc. Other specific point values ​​within this numerical range can be selected, which will not be described here one by one.

[0022] Preferably, the mass concentration of sodium alginate in the sodium alginate solution is 1%-5%, for example, it can be 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, etc. Other specific point values ​​within this numerical range can be selected and will not be described here one by one.

[0023] Preferably, the mass concentration of calcium chloride in the calcium chloride solution is 0.5%-2%, for example, it can be 0.5%, 0.75%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2%, etc. Other specific point values ​​within this numerical range can be selected, which will not be repeated here.

[0024] Preferably, the active ingredient is also mixed with a cationic polymer before mixing with the carrier solution.

[0025] Preferably, the microsphere droplets in the lower layer are collected by centrifugation and then dried.

[0026] Preferably, the drying comprises spray drying.

[0027] In a third aspect, the present invention provides a use of the microcapsule for promoting protein hydrolysis according to the first aspect or the preparation method according to the second aspect in preparing a product for improving protein digestion and hydrolysis.

[0028] Compared with the prior art, the present invention has the following beneficial effects:

[0029] Microcapsules with specific structures are obtained by encapsulating specific complex enzyme combinations with specific carrier materials. Among them, aminopeptidase and papain work synergistically to further enhance the digestion and hydrolysis of proteins. The prepared microcapsule products can be stably released in the small intestine after entering the digestive system, effectively promoting protein hydrolysis without affecting the original function of gastrointestinal protein digestion. This has positive significance for restoring and maintaining the body's own digestion and absorption functions, and enhancing the body's self-immunity and disease resistance. DETAILED DESCRIPTION

[0030] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0031] The aminopeptidase involved in the following examples is a product with a specification of 60000 U / g purchased from Guangzhou Jiaye Food Ingredients Co., Ltd.

[0032] Papain was purchased from Guangzhou Jiaye Food Ingredients Co., Ltd. with a specification of 100,000 U / g;

[0033] Trypsin was purchased from Guangzhou Jiaye Food Ingredients Co., Ltd. with a specification of 4000 U / g;

[0034] Bromelain was purchased from Guangzhou Jiaye Food Ingredients Co., Ltd. with a specification of 100,000 U / g.

[0035] Example 1

[0036] This embodiment provides a microcapsule for promoting protein hydrolysis, and the preparation method thereof is as follows:

[0037] (1) A composite enzyme powder obtained by mixing aminopeptidase powder and papain powder in a mass ratio of 2:5 was mixed with a PLGA / DDAB nanosphere suspension (enzyme powder: nanosphere = 100:1, w / w), and then centrifuged to remove the microsphere droplets in the lower layer for later use, wherein the amount of aminopeptidase powder used was 500 mg.

[0038] (2) The PLGA / DDAB nanosphere enzyme-loaded particles prepared in step (1) are resuspended in a 1% sodium alginate solution to prepare a suspension for later use.

[0039] (3) 20 ml of the suspension prepared in step (2) is added to a feed container, brought into the spray port by a peristaltic pump, and the peristaltic pump feed rate is set to 1 mL / min at 0.1 MPa, and sprayed into 40 mL of a calcium chloride solution with a mass concentration of 0.5% through a nozzle, and stirred at a speed of 300 rpm for 30 min to solidify, and then centrifuged at a speed of 2000 rpm for 5 min to remove the supernatant, and the microsphere droplets in the lower layer are washed with deionized water, and the microcapsules that promote protein hydrolysis are obtained after spray drying.

[0040] Example 2

[0041] This embodiment provides a microcapsule for promoting protein hydrolysis, and the preparation method thereof is as follows:

[0042] (1) A composite enzyme powder obtained by mixing aminopeptidase powder and papain powder in a mass ratio of 1:3 was mixed with a PLGA / DDAB nanosphere suspension (enzyme powder: nanosphere = 50:1, w / w), and then centrifuged to remove the microsphere droplets in the lower layer for later use, wherein the amount of aminopeptidase powder used was 500 mg.

[0043] (2) The PLGA / DDAB nanosphere enzyme-loaded particles prepared in step (1) are resuspended in a 3% sodium alginate solution to prepare a suspension for later use.

[0044] (3) 20 ml of the suspension prepared in step (2) is added to a feed container, brought into the spray port by a peristaltic pump, and the peristaltic pump feed rate is set to 1 mL / min at 0.1 MPa, and sprayed into 40 mL of a 2% calcium chloride solution through a nozzle, and stirred at a speed of 300 rpm for 30 min to solidify, and then centrifuged at a speed of 2000 rpm for 5 min to remove the supernatant, and the microsphere droplets in the lower layer are washed with deionized water, and the microcapsules that promote protein hydrolysis are obtained after spray drying.

[0045] Example 3

[0046] This embodiment provides a microcapsule for promoting protein hydrolysis, and the preparation method thereof is as follows:

[0047] (1) A composite enzyme powder obtained by mixing aminopeptidase powder and papain powder in a mass ratio of 1:1 was mixed with a PLGA / DDAB nanosphere suspension (enzyme powder: nanosphere = 65:1, w / w), and then centrifuged to remove the microsphere droplets in the lower layer for later use, wherein the amount of aminopeptidase powder used was 500 mg.

[0048] (2) Resuspending the PLGA / DDAB nanosphere enzyme-loaded particles prepared in step (1) in a 1.5% sodium alginate solution to prepare a suspension for later use.

[0049] (3) 20 ml of the suspension prepared in step (2) is added to a feed container, brought into the spray port by a peristaltic pump, and the peristaltic pump feed rate is set to 1 mL / min at 0.1 MPa, and sprayed into 40 mL of a calcium chloride solution with a mass concentration of 1% through a nozzle. The suspension is solidified by stirring at a speed of 300 rpm for 30 min, and then centrifuged at a speed of 2000 rpm for 5 min to remove the supernatant. The microsphere droplets in the lower layer are washed with deionized water and spray-dried to obtain the microcapsules that promote protein hydrolysis.

[0050] Comparative Example 1

[0051] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the papain powder in step (1) is replaced by an equal amount of bromelain powder.

[0052] Comparative Example 2

[0053] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the aminopeptidase powder in step (1) is replaced by an equal amount of trypsin powder.

[0054] Comparative Example 3

[0055] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the aminopeptidase powder in step (1) is replaced by an equal amount of bromelain powder.

[0056] Comparative Example 4

[0057] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the papain powder in step (1) is replaced by an equal amount of trypsin powder.

[0058] Comparative Example 5

[0059] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the composite enzyme powder in step (1) does not contain trypsin powder, and the total amount of the enzyme powder remains unchanged.

[0060] Comparative Example 6

[0061] This comparative example provides a microcapsule for promoting protein hydrolysis. The preparation method thereof is different from that of Example 1 only in that the composite enzyme powder in step (1) does not contain papain powder, and the total amount of the enzyme powder remains unchanged.

[0062] Test Example 1

[0063] Proteolytic effect test

[0064] 1 ml of the microcapsules prepared in Examples 1-3 and Comparative Examples 1-6 were mixed with 4 mL of deionized water, and then mixed with 2000 mg of meat powder (fish, pork, beef) for enzymatic hydrolysis at 37° C. and pH 6.8 for 4 h. The hydrolysis effect of each group of microcapsules on meat protein was tested by the following hydrolysis degree calculation formula: hydrolysis degree (DH%) = (h / h tot *100%), h: the number of peptide bonds cleaved per gram of protein after hydrolysis, millimoles (mmol / g), h tot : Millimoles of peptide bonds per gram of original protein (mmol / g) in %, the results are shown in Table 1:

[0065] Table 1

[0066]

[0067] From the data in the table, we can see that:

[0068] It can be seen from Examples 1 to 3 that the microcapsule product provided by the present invention has an excellent protein hydrolysis effect. By comparing Example 1 with Comparative Examples 1-6, it can be seen that when trypsin powder or bromelain powder is used to replace aminopeptidase powder or papain powder in Examples 1-4, the hydrolysis effect of the microcapsule product prepared therefrom is worse than that of Example 1; when any one of aminopeptidase or papain is lacking in Comparative Examples 5-6, the hydrolysis degree of the microcapsule product prepared therefrom is also lower than that of Example 1. It can be seen that the combination of aminopeptidase and papain in the present invention can synergistically improve the hydrolysis effect on meat protein and has a better enzymatic effect.

[0069] Test Example 2

[0070] Acid and alkali resistance test

[0071] Take the microcapsules prepared in Example 1 and the separate composite enzyme powder (aminopeptidase powder and papain powder in a mass ratio of 2:5) and place them in 20mL of buffer solutions with pH values ​​of 2, 4, 6, 7, and 8, respectively. The composite enzyme powder and the microcapsules contain the same amount of enzyme. After heating in a 40°C water bath for 1h, centrifuge at a speed of 5000rpm for 5min, remove the supernatant, and use deionized water centrifugation washing 3 times (5000rpm, 5min) for wall breaking treatment, and determine the enzyme activity. The enzyme activity retention rate is calculated by the following formula: enzyme activity retention rate = measured enzyme activity / relative enzyme activity × 100%, wherein the relative enzyme activity is the enzyme activity measured at pH 7, and the test results are shown in Table 2:

[0072] Table 2

[0073]

[0074] It can be seen from the data in the table that the microcapsules prepared by the present invention have an obvious protective effect on the embedded enzymes at different pH values, and microcapsules with stable properties in acidic and alkaline environments are prepared.

[0075] Test Example 3

[0076] Thermal stability test

[0077] The microcapsules prepared in Example 1 and the separate composite enzyme powder (aminopeptidase powder and papain powder in a mass ratio of 2:5) were placed in a constant temperature water bath at 30°C, 40°C, 50°C, 60°C, and 70°C and heated for 60 min, then the outer wall of the sample tube was immediately rinsed with running tap water, cooled, and then the wall was broken to measure the enzyme activity. The enzyme activity retention rate was calculated by the following formula: enzyme activity retention rate = measured enzyme activity / relative enzyme activity × 100%, where the relative enzyme activity is the enzyme activity measured at a temperature of 40°C. The test results are shown in Table 3:

[0078] Table 3

[0079]

[0080] It can be seen from the data in the table that as the temperature increases, the enzyme activity retention of the composite protease first increases and then decreases. As the temperature increases, the optimum temperature of the enzyme is reached, and the further increase in temperature destroys the structure of the protease, causing the enzyme activity to decrease, so the enzyme activity retention rate shows a trend of first increasing and then decreasing. Under different temperatures, the microcapsules embedded with the composite enzyme prepared in Example 1 of the present invention have significantly improved enzyme activity retention rates compared to the single composite enzyme.

[0081] Test Example 4

[0082] Storage stability test

[0083] The microcapsules prepared in Example 1 and a separate composite enzyme powder (aminopeptidase powder and papain powder in a mass ratio of 2:5) were placed at 4°C and 25°C for storage, respectively. The test was carried out for 15 days, and the enzyme activity was measured on the 0th, 1st, 3rd, 5th, 7th, 9th, 11th, 13th and 15th days, respectively. The enzyme activity retention rate was calculated by the following formula: enzyme activity retention rate = measured enzyme activity / relative enzyme activity × 100%, wherein the relative enzyme activity is the enzyme activity measured at the temperature of the storage day 0, and the test results are shown in Table 4:

[0084] Table 4

[0085]

[0086] It can be seen from the data in the table that the enzyme activity retention rate gradually decreases with the extension of storage time, and the storage temperature has a greater impact on the enzyme activity of the composite enzyme capsule. The storage condition of 25°C has a greater impact on the enzyme activity retention rate of the composite enzyme capsule than the low temperature (4°C) storage condition, and the difference between the two is more significant as the storage time increases. It can be seen that the microcapsules embedded with composite enzymes prepared in Example 3 of the present invention have a significantly improved enzyme activity retention rate compared to the single composite enzyme, which can reduce the impact of storage time and temperature on the enzyme activity retention rate and improve stability.

[0087] Test Example 5

[0088] Gastrointestinal fluid stability simulation test

[0089] (1) Simulated gastric fluid (pH = 2): Mix 31 mL of concentrated hydrochloric acid with 235 mL of deionized water, add 1 g of pepsin and mix well to obtain simulated gastric fluid.

[0090] (2) Simulated intestinal fluid (pH = 6.8): Take 0.68 g of potassium dihydrogen phosphate and mix it with 50 mL of deionized water. Use 0.1 mol / L sodium hydroxide solution to adjust the pH to 6.8, and then mix it with 50 mL of 20 mg / mL trypsin solution (the solvent is water) to obtain simulated intestinal fluid.

[0091] 1 mL of the microcapsule product prepared in Example 1 was mixed with 30 mL of simulated gastric juice, and the mixture was shaken at 37° C. and 100 r / min for 2 h. 30 mL of simulated intestinal fluid was added, and the mixture was shaken for 4 h under the same conditions. The enzyme activity of the product was measured every 1 h during the test, and the enzyme activity retention rate was calculated by the following formula: enzyme activity retention rate = measured enzyme activity / relative enzyme activity × 100%, wherein the relative enzyme activity is the enzyme activity at the temperature of 0 h (100%). The test results are shown in Table 5:

[0092] Table 5

[0093] Processing time Example 1 1h 91.23±0.26 2h 88.24±0.61 3h 40.65±0.26 4h 32.36±0.65 5h 29.37±0.31 6h 25.03±0.60

[0094] From the data in the table, we can see that:

[0095] The microcapsule product embedded with the complex enzyme obtained in Example 1 of the present invention has an enzyme activity retention rate of 88.24±0.61% after 2 hours of simulated gastric juice, and an enzyme activity retention rate of 25.03±0.60% after 6 hours of simulated intestinal juice. If the microcapsule is unstable in gastric juice, it is easy to cause the complex enzyme to be released and then inactivated in gastric juice, resulting in a decrease in the bioavailability of the complex enzyme; and the microcapsule reaches the small intestine immediately after preliminary digestion in gastric juice. If the microcapsule is relatively stable in the small intestinal juice and the structure is difficult to be destroyed, it will cause the complex protease to be unable to be released, affecting the digestive effect of the complex protease, resulting in a significant decrease in its bioavailability. The microcapsule product of a specific structure obtained by encapsulating a specific complex enzyme combination with a specific carrier material of the present invention can further reduce the release in gastric juice while ensuring that it can be stably released in large quantities after reaching the intestine.

[0096] In summary, the present invention uses a specific carrier material to encapsulate a specific complex enzyme combination to obtain a microcapsule with a specific structure, wherein aminopeptidase and papain synergistically enhance each other, which can further enhance the digestion and hydrolysis effect of protein. The prepared microcapsule product can be stably released in the small intestine after entering the digestive system, effectively promoting protein hydrolysis, and does not affect the original function of gastrointestinal protein digestion, which has a positive significance for restoring and maintaining the inherent digestion and absorption function, and enhancing the body's self-immunity and disease resistance.

[0097] The applicant declares that the present invention illustrates the technical solution of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

[0098] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.

[0099] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.

Claims

1. A microcapsule for promoting protein hydrolysis, characterized in that: The microcapsule for promoting protein hydrolysis comprises a carrier material and an active ingredient embedded in the carrier material; The active ingredients include a combination of aminopeptidase and papain; The carrier material includes a combination of sodium alginate and calcium chloride.

2. The microcapsule for promoting protein hydrolysis according to claim 1, characterized in that: The mass ratio of the aminopeptidase to papain is (0.5-2):(2-5).

3. The microcapsule for promoting protein hydrolysis according to claim 1, characterized in that: The mass ratio of the sodium alginate to calcium chloride is (1-3):(0.5-2).

4. The microcapsule for promoting protein hydrolysis according to any one of claims 1 to 3, characterized in that: The microcapsules promoting protein hydrolysis also include a cationic polymer embedded in a carrier material; Preferably, the cationic polymer comprises PLGA / DDAB nanomaterial; Preferably, the mass ratio of the active ingredient to the cationic polymer is (50-100):

1.

5. A method for preparing a microcapsule for promoting protein hydrolysis according to any one of claims 1 to 4, characterized in that: The preparation method comprises: After the active ingredient and the carrier material solution are mixed, the microsphere droplets in the lower layer are collected by centrifugation to obtain the microcapsules that promote protein hydrolysis.

6. The preparation method according to claim 5, characterized in that: The carrier material solution includes a sodium alginate solution and a sodium chloride solution.

7. The preparation method according to claim 5, characterized in that: The mixing is carried out under stirring conditions; Preferably, the stirring speed is 200-500 rpm; Preferably, the mixing time is 30-60 min.

8. The preparation method according to claim 6, characterized in that: The mass concentration of sodium alginate in the sodium alginate solution is 1%-5%; Preferably, the mass concentration of calcium chloride in the calcium chloride solution is 0.5%-2%.

9. The preparation method according to claim 5, characterized in that: The active ingredient is also mixed with a cationic polymer before mixing with the carrier solution; Preferably, the microsphere droplets collected by centrifugation at the lower layer are also dried; Preferably, the drying comprises spray drying.

10. Use of the microcapsule for promoting protein hydrolysis according to any one of claims 1 to 4 or the preparation method according to any one of claims 5 to 9 in preparing a product for improving protein digestion and hydrolysis.